Phosphorus Dendrimers Co-deliver Fibronectin and Edaravone for Combined Ischemic Stroke Treatment via Cooperative Modulation of Microglia/Neurons and Vascular Regeneration
© 2024 Wiley‐VCH GmbH..
The development of new multi-target combination treatment strategies to tackle ischemic stroke (IS) remains to be challenging. Herein, a proof-of-concept demonstration of an advanced nanomedicine formulation composed of macrophage membrane (MM)-camouflaged phosphorous dendrimer (termed as AK137)/fibronectin (FN) nanocomplexes (NCs) loaded with antioxidant edaravone (EDV) to modulate both microglia and neurons for effective IS therapy is showcased. The created MMAK137-FN/EDV (M@A-F/E) NCs with a mean size of 260 nm possess good colloidal stability, sustained EDV release kinetics, and desired cytocompatibility. By virtue of MM decoration, the M@A-F/E NCs can cross blood-brain barrier, act on microglia to exert the anti-inflammatory (AK137 and FN) and antioxidative (FN and EDV) effects in vitro for oxidative stress alleviation, microglia M2 polarization, and reduction of pro-inflammatory cytokine secretion, and act on neuron cells to be anti-apoptotic. In a transient middle cerebral artery occlusion rat model, the developed M@A-F/E NCs can exert enhanced antioxidant/anti-inflammatory/anti-apoptotic therapeutic effects to comprehensively regulate the brain microenvironment and promote vascular regeneration to collaboratively restore the blood flow after ischemia-reperfusion. The designed MM-coated NCs composed of all-active ingredients of phosphorous dendrimers, FN, and EDV that can fully regulate the brain inflammatory microenvironment may expand their application scope in other neurodegenerative diseases.
Media Type: |
Electronic Article |
---|
Year of Publication: |
2024 |
---|---|
Publication: |
2024 |
Contained In: |
To Main Record - year:2024 |
---|---|
Contained In: |
Advanced healthcare materials - (2024) vom: 05. Aug., Seite e2401462 |
Language: |
English |
---|
Contributors: |
Ma, Jie [Author] |
---|
Links: |
---|
Keywords: |
Fibronectin |
---|
Notes: |
Date Revised 05.08.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.1002/adhm.202401462 |
---|
funding: |
|
---|---|
Supporting institution / Project title: |
|
PPN (Catalogue-ID): |
NLM37588730X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM37588730X | ||
003 | DE-627 | ||
005 | 20240805232950.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240805s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/adhm.202401462 |2 doi | |
028 | 5 | 2 | |a pubmed24n1492.xml |
035 | |a (DE-627)NLM37588730X | ||
035 | |a (NLM)39101311 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Ma, Jie |e verfasserin |4 aut | |
245 | 1 | 0 | |a Phosphorus Dendrimers Co-deliver Fibronectin and Edaravone for Combined Ischemic Stroke Treatment via Cooperative Modulation of Microglia/Neurons and Vascular Regeneration |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 05.08.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a © 2024 Wiley‐VCH GmbH. | ||
520 | |a The development of new multi-target combination treatment strategies to tackle ischemic stroke (IS) remains to be challenging. Herein, a proof-of-concept demonstration of an advanced nanomedicine formulation composed of macrophage membrane (MM)-camouflaged phosphorous dendrimer (termed as AK137)/fibronectin (FN) nanocomplexes (NCs) loaded with antioxidant edaravone (EDV) to modulate both microglia and neurons for effective IS therapy is showcased. The created MMAK137-FN/EDV (M@A-F/E) NCs with a mean size of 260 nm possess good colloidal stability, sustained EDV release kinetics, and desired cytocompatibility. By virtue of MM decoration, the M@A-F/E NCs can cross blood-brain barrier, act on microglia to exert the anti-inflammatory (AK137 and FN) and antioxidative (FN and EDV) effects in vitro for oxidative stress alleviation, microglia M2 polarization, and reduction of pro-inflammatory cytokine secretion, and act on neuron cells to be anti-apoptotic. In a transient middle cerebral artery occlusion rat model, the developed M@A-F/E NCs can exert enhanced antioxidant/anti-inflammatory/anti-apoptotic therapeutic effects to comprehensively regulate the brain microenvironment and promote vascular regeneration to collaboratively restore the blood flow after ischemia-reperfusion. The designed MM-coated NCs composed of all-active ingredients of phosphorous dendrimers, FN, and EDV that can fully regulate the brain inflammatory microenvironment may expand their application scope in other neurodegenerative diseases | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a fibronectin | |
650 | 4 | |a ischemic stroke | |
650 | 4 | |a microglia polarizations | |
650 | 4 | |a phosphorus dendrimers | |
650 | 4 | |a revascularization | |
700 | 1 | |a Zhan, Mengsi |e verfasserin |4 aut | |
700 | 1 | |a Sun, Huxiao |e verfasserin |4 aut | |
700 | 1 | |a He, Liangyu |e verfasserin |4 aut | |
700 | 1 | |a Zou, Yu |e verfasserin |4 aut | |
700 | 1 | |a Huang, Tianyu |e verfasserin |4 aut | |
700 | 1 | |a Karpus, Andrii |e verfasserin |4 aut | |
700 | 1 | |a Majoral, Jean-Pierre |e verfasserin |4 aut | |
700 | 1 | |a Mignani, Serge |e verfasserin |4 aut | |
700 | 1 | |a Shen, Mingwu |e verfasserin |4 aut | |
700 | 1 | |a Shi, Xiangyang |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Advanced healthcare materials |d 2012 |g (2024) vom: 05. Aug., Seite e2401462 |w (DE-627)NLM218710070 |x 2192-2659 |7 nnns |
773 | 1 | 8 | |g year:2024 |g day:05 |g month:08 |g pages:e2401462 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/adhm.202401462 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_NLM | ||
912 | |a GBV_ILN_39 | ||
951 | |a AR | ||
952 | |j 2024 |b 05 |c 08 |h e2401462 |